Top Markets
Coin of the day
Opiant Pharmaceuticals, Inc. Opiant Pharmaceuticals, Inc.

Opiant Pharmaceuticals, Inc.

OPNT
Kedudukan dalam Saham #22841
Opiant Pharmaceuticals, Inc. functions as a specialized pharmaceutical... Opiant Pharmaceuticals, Inc. functions as a specialized pharmaceutical enterprise, primarily focused on inventing remedies for both various addictions and drug overdoses. A key product in their current portfolio is NARCAN nasal spray, which provides a critical solution for counteracting opioid overdoses. Their development pipeline is robust, featuring several promising drug candidates designed to address further opioid overdose reversal needs, alcohol use disorders, acute cannabinoid overdose, and opioid use disorders. The company, which established itself in 2005, was initially named Lightlake Therapeutics Inc. before rebranding as Opiant Pharmaceuticals, Inc. in January 2016. Its corporate headquarters are located in Santa Monica, California.
Harga Saham
$20.65
Disegerakkan terakhir: 2023-03-01
Modal Pasaran
$82.52M
Perubahan (1 hari)
-0.58%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Opiant Pharmaceuticals, Inc. (OPNT)

Kategori

Harga OPNT dengan permodalan pasaran b
Opiant Pharmaceuticals, Inc. Opiant Pharmaceuticals, Inc.
OPNT
$20.65
Modal pasaran bagi Opiant Pharmaceuticals, Inc.(OPNT)
Modal Pasaran: $82.52M
Sehingga August 2026, Opiant Pharmaceuticals, Inc. mempunyai modal pasaran sebanyak $82.52M. Ini menjadikan Opiant Pharmaceuticals, Inc. syarikat ke-22841st paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran Opiant Pharmaceuticals, Inc. dari 2017 hingga 2026
OPNT berbanding dengan 5 teratas yang paling popular stocks
Harga OPNT Aset B Pasaran B Hasilnya
Opiant Pharmaceuticals, Inc. Opiant Pharmaceuticals, Inc.
$1,304,152 $82.52M
$5.211T +6,315,404.91%
Opiant Pharmaceuticals, Inc. Opiant Pharmaceuticals, Inc.
$1,137,829 $82.52M
$4.547T +5,509,967.93%
Opiant Pharmaceuticals, Inc. Opiant Pharmaceuticals, Inc.
$1,041,665 $82.52M
$4.162T +5,044,282.38%
Opiant Pharmaceuticals, Inc. Opiant Pharmaceuticals, Inc.
$899,100 $82.52M
$3.593T +4,353,897.56%
Opiant Pharmaceuticals, Inc. Opiant Pharmaceuticals, Inc.
$698,915 $82.52M
$2.793T +3,384,478.13%